ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,752Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 2061

$1.69M Total Retail Price of All Prescriptions

Rank: 25 out of 2061

924 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 924 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 924 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 26,960 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
FUROSEMIDE 1,174 1,046 1 6
OMEPRAZOLE 1,157 1,026 2 5
LEVOTHYROXINE SODIUM 1,143 1,000 3 3
METOPROLOL TARTRATE 960 876 4 7
WARFARIN SODIUM 856 769 5 11
SIMVASTATIN 798 713 6 1
LISINOPRIL 680 608 7 2
HYDROCODONE-ACETAMINOPHEN 673 603 S3 8 10
AMLODIPINE BESYLATE 665 640 9 4
POTASSIUM CHLORIDE 632 574 10 16
TRAZODONE HCL 503 439 11 39
TRAMADOL HCL 443 404 12 18
CITALOPRAM HBR 438 369 13 20
LOVASTATIN 390 367 14 35
METFORMIN HCL 369 322 15 9
HYDROCHLOROTHIAZIDE 366 352 16 12
ATORVASTATIN CALCIUM 349 312 17 8
NOVOLOG 349 267 17 102
GABAPENTIN 320 259 19 15
ISOSORBIDE MONONITRATE ER 317 313 20 42
ALENDRONATE SODIUM 314 297 21 25
ATENOLOL 294 269 22 13
LOSARTAN POTASSIUM 281 279 23 17
LANTUS 248 193 24 48
FLUOXETINE HCL 245 210 25 73
METOPROLOL SUCCINATE 244 242 26 19
OXYCODONE-ACETAMINOPHEN 242 165 S2 27 36
POLYETHYLENE GLYCOL 3350 238 195 28 64
DIGOXIN 231 220 29 56
DONEPEZIL HCL 225 225 30 24
CLOPIDOGREL 217 196 31 29
PREDNISONE 216 188 32 32
MIRTAZAPINE 213 188 33 46
CARVEDILOL 208 198 34 22
MELOXICAM 195 158 35 44
PRAVASTATIN SODIUM 195 171 35 14
TAMSULOSIN HCL 194 170 37 30
SERTRALINE HCL 191 164 38 21
ZETIA 189 188 39 68
ALLOPURINOL 185 175 40 28
CEPHALEXIN 179 165 41 112
FLUTICASONE PROPIONATE 171 156 42 43
ENALAPRIL MALEATE 171 166 42 75
NEXIUM 156 126 44 26
CYMBALTA 154 118 45 59
JANUVIA 152 139 46 51
BUSPIRONE HCL 144 120 47 115
SPIRONOLACTONE 144 95 47 62
KLOR-CON M20 142 122 49 47
KLOR-CON M10 139 114 50 125
CARBIDOPA-LEVODOPA 139 134 50 97
HALOPERIDOL 137 132 52 153
OXYBUTYNIN CHLORIDE ER 133 130 53 80
PLAVIX 131 117 54 49
ALBUTEROL SULFATE 130 122 55 104
ACTOS 128 124 56 140
FAMOTIDINE 128 105 56 67
ZOLPIDEM TARTRATE 125 118 58 23
SULFAMETHOXAZOLE-TRIMETHOPRIM 124 97 59 87
GLIMEPIRIDE 122 122 60 33
NAMENDA 120 119 61 37
GLYBURIDE 120 116 R 61 60
IPRATROPIUM BROMIDE 119 108 63 167
OXYBUTYNIN CHLORIDE 118 108 64 121
PROAIR HFA 118 115 64 40
DIOVAN 118 106 64 41
RISPERIDONE 117 101 67 66
PHENYTOIN SODIUM EXTENDED 116 80 68 145
BENZTROPINE MESYLATE 114 102 R 69 149
METOCLOPRAMIDE HCL 113 95 70 138
AMIODARONE HCL 106 91 71 168
HUMALOG 104 83 72 163
PANTOPRAZOLE SODIUM 104 93 72 45
AZITHROMYCIN 104 93 72 34
LANTUS SOLOSTAR 103 91 75 76
DOXYCYCLINE HYCLATE 102 91 76 98
LYRICA 101 70 77 83
ROPINIROLE HCL 98 77 78 92
VENLAFAXINE HCL ER 95 73 79 109
NYSTOP 93 80 80 185
RANITIDINE HCL 90 76 81 53
ADVAIR DISKUS 90 90 81 57
SPIRIVA 88 88 83 63
LEVEMIR 86 42 84 225
VERAPAMIL ER 85 72 85 100
PAROXETINE HCL 84 73 86 61
EXELON 82 82 87 94
FINASTERIDE 82 70 87 86
NOVOLOG FLEXPEN 81 66 89 177
AMITIZA 81 40 89 368
TRIAMTERENE-HCTZ 78 78 91 38
FENTANYL 76 76 S2 92 84
ALPRAZOLAM 75 75 93 85
CLONIDINE HCL 74 69 94 52
OXYCONTIN 74 36 S2 94 154
PEN NEEDLE 73 59 96 116
LANSOPRAZOLE 72 59 97 139
ACTONEL 72 58 97 231
MORPHINE SULFATE ER 71 35 S2 99 166
EVISTA 69 69 100 150
LEVOFLOXACIN 68 60 101 111
BYSTOLIC 68 64 101 130
DILTIAZEM 24HR CD 68 68 101 118
PIOGLITAZONE HCL 67 65 R 104 292
CYCLOBENZAPRINE HCL 65 37 R 105 78
IBUPROFEN 64 54 106 90
PERPHENAZINE 63 63 107 381
ESCITALOPRAM OXALATE 63 26 107 77
SINGULAIR 62 59 109 88
DIOVAN HCT 62 54 109 99
ACETIC ACID 61 54 111 388
NITROSTAT 61 59 111 226
LOSARTAN-HYDROCHLOROTHIAZIDE 61 59 111 50
OXYCODONE HCL 60 38 S2 114 82
METRONIDAZOLE 60 44 114 223
AGGRENOX 59 56 116 279
DIVALPROEX SODIUM 59 47 116 74
ACETAMINOPHEN-CODEINE 58 56 S3 118 144
NIFEDIPINE ER 58 56 118 134
RESTASIS 57 26 120 339
LIPITOR 55 46 121 70
NYSTATIN 54 52 122 148
SYNTHROID 53 53 123 58
AMLODIPINE BESYLATE-BENAZEPRIL 51 51 124 79
MONTELUKAST SODIUM 50 49 125 176
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 50 125 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.